Conference paper

HOW DO WE TREAT PEOPLE WITH DEMENTIA IN CROATIA

Ninoslav Mimica ; Psychiatric Hospital Vrapče, Bolnička cesta 32, HR-10090 Zagreb, Croatia; School of Medicine, University of Zagreb, Šalata 3b, HR-10000 Zagreb, Croatia
Paola Presečki ; Psychiatric Hospital Sveti Ivan, Jankomir 11, HR-10090 Zagreb, Croatia, Croatia

Abstract

The current clinical view on pharmacological treatment and the Croatian reality regarding approved antidementia drugs is
presented. Dementia is a syndrome of high incidence and Alzheimer’s disease is the most common cause of dementia. New data show that dementia prevalence will nearly double every 20 years, and we believe that current estimated number of persons with dementia (PWD) for Croatia is more than 80,000. The standard treatment with antidementia drugs is unavailable in Croatia, for the majority of PWD, because antidementia drugs are not on the reimbursement list, although Croatian algorithm for psychopharmacologicaltreatment and Alzheimer Disease Societies Croatia recommend early and adequate treatment. Alzheimer's dementia is becoming a world’s health priority in 21st century, so we strongly believe that antidementia drugs should be reimbursed in Croatia.

Keywords

Alzheimer’s disease; dementia; Croatia; antidementia drugs; cholinesterase inhibitors; memantine

Hrčak ID:

55870

URI

https://hrcak.srce.hr/55870

Publication date:

30.6.2010.

Visits: 1.748 *